awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33394505-4B9D31A1-1115-4606-ACEF-BDE2E39D1D5B
Q33394505-4B9D31A1-1115-4606-ACEF-BDE2E39D1D5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394505-4B9D31A1-1115-4606-ACEF-BDE2E39D1D5B
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.
P2860
Q33394505-4B9D31A1-1115-4606-ACEF-BDE2E39D1D5B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394505-4B9D31A1-1115-4606-ACEF-BDE2E39D1D5B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61228d27ea493f233ca7a2e7c92d1a81a3c041e0
P2860
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.